Advocacy related to trade enforcement, consumer product safety, intellectual property protection, online marketplace practices, and regulatory policy affecting U.S. manufacturers of maternal and infant health products.
2026 · 2nd Quarter (Apr 1 - June 30)
DR. BROWNS COMPANY
Filed by DB3, LLC (FKA THE DASCHLE GROUP).
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Jun 5, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- DB3, LLC (FKA THE DASCHLE GROUP)
- Client
- DR. BROWNS COMPANY
- Filing UUID
- 16af8a98-eff7-493a-a275-c91d8fc6c09f
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Advocacy related to trade enforcement, consumer product safety, intellectual property protection, online marketplace practices, and regulatory policy affecting U.S. manufacturers of maternal and infant health products.
Advocacy related to trade enforcement, consumer product safety, intellectual property protection, online marketplace practices, and regulatory policy affecting U.S. manufacturers of maternal and infant health products.
Advocacy related to trade enforcement, consumer product safety, intellectual property protection, online marketplace practices, and regulatory policy affecting U.S. manufacturers of maternal and infant health products.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.